Early postoperative magnetic resonance imaging following nonneoplastic cortical resection

Journal of Neurosurgery
M M HenegarD L Silbergeld

Abstract

Postcraniotomy residual tumor is often determined by magnetic resonance (MR) imaging. Magnetic resonance changes that occur in the postoperative setting must be defined to ensure both the optimum timing of postoperative image acquisition and the accurate assessment of images for residual tumor. Postoperative changes in nontumor parenchyma have previously been described for computerized tomography but not for MR imaging. In the present study, 11 patients without intracranial neoplastic disease (six females and five males with a median age of 36 years) submitted to MR imaging 17 to 28 hours after undergoing temporal lobectomies for epilepsy. Four of the operations were performed with the patients under general anesthesia and seven under local anesthesia. Postoperative MR images (T1-weighted, T1-weighted gadolinium enhanced, and T2-weighted) were reviewed. Extraaxial fluid, air, or blood was present in all cases. Enhancement of the resection bed parenchyma occurred in seven (64%) of 11 patients. In three of the remaining four patients, assessment of parenchymal enhancement was obscured by extraaxial fluid collections. Dural enhancement occurred adjacent to the resection site in all of the cases and remotely in 73%. Eight (73%) of ...Continue Reading

References

Jan 1, 1990·Radiology·A D Elster, D A DiPersio
Mar 1, 1990·Journal of Computer Assisted Tomography·S WakaiM Nagai
Sep 1, 1990·Journal of Neurosurgery·V LaohaprasitH R Winn
Mar 1, 1989·Neurology·N A VickA Walsh
May 1, 1988·Journal of Neurosurgery·P C BurgerP Kleihues
May 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J KinsellaE Glastein
Dec 1, 1988·Journal of Neuro-oncology·J NewallB Kaplan
Feb 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R WoodW R Shapiro
Apr 1, 1987·Journal of Neurosurgery·G A Ojemann
Jun 1, 1985·Annals of Neurology·J G CairncrossR F DelMaestro
Feb 1, 1969·Archives of Neurology·R Jelsma, P C Bucy
Sep 1, 1980·Neurology·F H Hochberg, A Pruitt
Sep 1, 1982·Annals of Neurology·W R Shapiro
May 1, 1981·Radiology·B F JeffriesJ Krempa
Sep 1, 1994·Neurosurgery·J AhmadiW T Couldwell
Jun 1, 1964·Journal of Neurosurgery·E HITCHCOCK, R SATO
Jul 1, 1960·Journal of Neurosurgery·J G ROTH, A R ELVIDGE

❮ Previous
Next ❯

Citations

Oct 24, 2000·Journal of Magnetic Resonance Imaging : JMRI·M BuchfelderC Nimsky
Jul 15, 2011·Neuroradiology·Maaike J VosTjeerd J Postma
Mar 10, 2005·Pediatric Radiology·Elysa WidjajaPaul D Griffiths
Apr 29, 2010·Current Oncology Reports·Patrick Y WenEudocia Quant
Nov 19, 2010·Current Oncology Reports·Eudocia C Quant, Patrick Y Wen
Jan 22, 2003·European Journal of Radiology·Gazanfer EkinciNecmettin Pamir
Feb 12, 2011·Neuro-oncology·David A ReardonPatrick Y Wen
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentSusan M Chang
Nov 30, 1999·Journal of Neurosurgery·G R SutherlandJ Saunders
Apr 2, 2008·Journal of Neurosurgery. Pediatrics·Saskia E LuijnenburgJonathan I M L Verbeke
Aug 31, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Nicolas DeaDavid Fortin
Mar 17, 2010·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Audrey G Sinclair, Daniel J Scoffings
May 7, 2013·Magnetic Resonance Imaging Clinics of North America·Mark S ShiroishiMeng Law
Mar 24, 2012·Neurosurgery Clinics of North America·Joshua Lucas, Gabriel Zada
May 12, 2007·Neuroimaging Clinics of North America·A Talia VertinskyRoland Bammer
Oct 31, 2013·Critical Reviews in Oncology/hematology·Mariska SieEveline S J M de Bont
Jun 6, 2016·Current Treatment Options in Oncology·Sylvia C EiseleEudocia Q Lee
Oct 8, 2016·Neuroimaging Clinics of North America·Mark F Dalesandro, Jalal B Andre
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Jul 25, 2003·Seminars in Ultrasound, CT, and MR·Robert C WallaceRobert F Spetzler
Jan 11, 2011·Technology in Cancer Research & Treatment·M S ShiroishiM Law
Oct 19, 2004·Neuropathology and Applied Neurobiology·E A NeuweltR Nixon
Jul 19, 2014·Clinical Nuclear Medicine·Maria M D'SouzaRajendra P Tripathi
Feb 4, 1998·Journal of Computer Assisted Tomography·U SpetzgerJ M Gilsbach
Mar 10, 2011·Expert Opinion on Pharmacotherapy·Jan Nyrop JakobsenHans Skovgaard Poulsen
Oct 29, 2000·Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·R BergmanR E Wright
Jan 23, 2018·NMC Case Report Journal·Takuma NakashimaYukio Seki
Sep 27, 2018·Emergency Radiology·Komal A ChughtaiAlok A Bhatt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.